Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$32.9 - $47.0 $7.04 Million - $10.1 Million
-214,091 Reduced 50.0%
214,091 $7.11 Million
Q2 2024

Aug 14, 2024

BUY
$32.9 - $47.0 $6.97 Million - $9.96 Million
211,833 Added 97.91%
428,182 $14.2 Million
Q1 2024

May 15, 2024

BUY
$41.76 - $74.73 $1.24 Million - $2.22 Million
29,721 Added 15.93%
216,349 $10.4 Million
Q4 2023

Feb 14, 2024

SELL
$58.16 - $75.44 $1.16 Million - $1.5 Million
-19,943 Reduced 9.65%
186,628 $13.8 Million
Q3 2023

Nov 14, 2023

BUY
$70.9 - $88.63 $376,762 - $470,979
5,314 Added 2.64%
206,571 $15.1 Million
Q2 2023

Aug 14, 2023

BUY
$81.09 - $94.16 $2.76 Million - $3.21 Million
34,088 Added 20.39%
201,257 $16.7 Million
Q1 2023

May 15, 2023

SELL
$82.98 - $91.46 $172,349 - $189,962
-2,077 Reduced 1.23%
167,169 $14.9 Million
Q4 2022

Feb 14, 2023

BUY
$66.93 - $97.5 $11.3 Million - $16.5 Million
169,246 New
169,246 $14.5 Million

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $2.69B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.